Cinctive Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-40,000
Closed -$5.12M – 541
2022
Q1
$5.12M Buy
40,000
+16,000
+67% +$1.75M 0.19% 175
2021
Q4
$3.22M Buy
+24,000
New +$3.45M 0.14% 231

Other funds holding DXCM

Cinctive Capital Management's DXCM Position: Q2 2026 in Review

Cinctive Capital Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 35,640 shares — an estimated $2.24M sold.

Cinctive Capital Management first reported a position in DXCM in Q1 2020 and held it in 13 quarters. The position peaked at $8.69M in Q2 2023. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cinctive Capital Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 35,640 DexCom shares in Q2 2026, an estimated $2.24M.
  • Cinctive Capital Management first reported a position in DexCom in Q1 2020 and held it in 13 quarters.
  • Cinctive Capital Management's DexCom position peaked at $8.69M in Q2 2023.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.